Wei-Fan Hsu Selected Research

Fetal Proteins (Fetoprotein)

1/2023	Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
1/2022	Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C.
8/2021	Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma.
1/2020	Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Fan Hsu Research Topics

Disease

11	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 08/2019
9	Chronic Hepatitis C 03/2024 - 01/2018
6	Fibrosis (Cirrhosis) 05/2022 - 01/2019
4	Hepatitis C 03/2024 - 04/2019
4	Neoplasms (Cancer) 11/2023 - 10/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2019
3	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2016
2	Liver Neoplasms (Liver Cancer) 10/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2020 - 01/2019
2	Chronic Hepatitis B 01/2019 - 01/2018
1	Fatty Liver 01/2024
1	Disease Progression 11/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Necrosis 11/2021
1	Liver Diseases (Liver Disease) 10/2021
1	Rheumatoid Arthritis 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 08/2019
1	Ascites 01/2019
1	Portal Hypertension 01/2019
1	Splenomegaly 10/2018
1	Protein C Deficiency 01/2015
1	Hemorrhage 01/2015

Drug/Important Bio-Agent (IBA)

6	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2018
4	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
4	Fetal Proteins (Fetoprotein)IBA 01/2023 - 01/2020
3	AlbuminsIBA 10/2022 - 07/2021
3	BilirubinIBA 10/2022 - 07/2021
2	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 07/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	NivolumabIBA 11/2021 - 01/2020
2	Ribavirin (Virazole)FDA LinkGeneric 10/2021 - 01/2020
2	InterferonsIBA 10/2021 - 01/2020
2	Everolimus FDA Link 08/2020 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	Nucleic AcidsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	regorafenibIBA 07/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 08/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Thioacetamide (Thioacetamid)IBA 01/2019
1	Thrombin FDA Link 01/2019
1	AntithrombinsIBA 01/2019
1	Thrombin Receptors (Thrombin Receptor)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Dabigatran FDA Link 01/2019
1	FibrinIBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018
1	AnticoagulantsIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2015
1	Lugol's solution (Lugol's iodine)IBA 10/2013

Therapy/Procedure

15	Therapeutics 03/2024 - 01/2015
2	Immunotherapy 11/2023 - 01/2023
1	Hospice Care (Care, Bereavement) 10/2022
1	Surgical Instruments (Clip) 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Splenectomy 10/2018
1	Liver Transplantation 01/2016